Literature DB >> 24900739

Contribution of Cage-Shaped Structure of Physalins to Their Mode of Action in Inhibition of NF-κB Activation.

Masaaki Ozawa1, Masaki Morita2, Go Hirai1, Satoru Tamura3, Masao Kawai4, Ayako Tsuchiya5, Kana Oonuma1, Keiji Maruoka6, Mikiko Sodeoka7.   

Abstract

A library of oxygenated natural steroids, including physalins, withanolides, and perulactones, coupled with the synthetic cage-shaped right-side structure of type B physalins, was constructed. SAR studies for inhibition of NF-κB activation showed the importance of both the B-ring and the oxygenated right-side partial structure. The 5β,6β-epoxy derivatives of both physalins and withanolides showed similar profiles of inhibition of NF-κB activation and appeared to act on NF-κB signaling via inhibition of phosphorylation and degradation of IκBα. In contrast, type B physalins with C5-C6 olefin functionality inhibited nuclear translocation and DNA binding of RelA/p50 protein dimer, which lie downstream of IκBα degradation, although withanolides having the same AB-ring functionality did not. These results indicated that the right-side partial structure of these steroids influences their mode of action.

Entities:  

Keywords:  NF-κB; Physalis plants; SAR; highly oxygenated steroid; physalin; synthetic analogues; withanolide

Year:  2013        PMID: 24900739      PMCID: PMC4027496          DOI: 10.1021/ml400144e

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  21 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Tautomerism between exomethylene type physalins and oxymethylene-bridged physalins.

Authors:  B Makino; M Kawai; H Yamamura; S Araki; Y Butsugan
Journal:  Pharmazie       Date:  2002-03       Impact factor: 1.267

Review 3.  Circuitry of nuclear factor kappaB signaling.

Authors:  Alexander Hoffmann; David Baltimore
Journal:  Immunol Rev       Date:  2006-04       Impact factor: 12.988

4.  Cytotoxic activity of physalins and related compounds against HeLa cells.

Authors:  M Kawai; B Makino; H Yamamura; S Araki; Y Butsugan; J Ohya
Journal:  Pharmazie       Date:  2002-05       Impact factor: 1.267

5.  Isolation, structures, and structure - cytotoxic activity relationships of withanolides and physalins from Physalis angulata.

Authors:  Amooru G Damu; Ping-Chung Kuo; Chung-Ren Su; Tsung-Hsiao Kuo; Tzu-Hsuan Chen; Kenneth F Bastow; Kuo-Hsiung Lee; Tian-Shung Wu
Journal:  J Nat Prod       Date:  2007-06-20       Impact factor: 4.050

6.  Synthesis of the DFGH ring system of type B physalins: highly oxygenated, cage-shaped molecules.

Authors:  Megumi Ohkubo; Go Hirai; Mikiko Sodeoka
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

Review 7.  Posttranslational modifications of NF-kappaB: another layer of regulation for NF-kappaB signaling pathway.

Authors:  Bo Huang; Xiao-Dong Yang; Acacia Lamb; Lin-Feng Chen
Journal:  Cell Signal       Date:  2010-04-02       Impact factor: 4.315

8.  Potential antitumor agents. XVII. physalin B and 25,26-epidihydrophysalin C from Witheringia coccoloboides.

Authors:  M D Antoun; D Abramson; R L Tyson; C J Chang; J L McLaughlin; G Peck; J M Cassady
Journal:  J Nat Prod       Date:  1981 Sep-Oct       Impact factor: 4.050

9.  Withaferin a strongly elicits IkappaB kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity.

Authors:  Mary Kaileh; Wim Vanden Berghe; Arne Heyerick; Julie Horion; Jacques Piette; Claude Libert; Denis De Keukeleire; Tamer Essawi; Guy Haegeman
Journal:  J Biol Chem       Date:  2006-12-06       Impact factor: 5.157

10.  Naturally occurring small-molecule inhibitors of hedgehog/GLI-mediated transcription.

Authors:  Takahiro Hosoya; Midori A Arai; Takashi Koyano; Thaworn Kowithayakorn; Masami Ishibashi
Journal:  Chembiochem       Date:  2008-05-05       Impact factor: 3.164

View more
  7 in total

1.  Withanolides from Aeroponically Grown Physalis peruviana and Their Selective Cytotoxicity to Prostate Cancer and Renal Carcinoma Cells.

Authors:  Ya-Ming Xu; E M Kithsiri Wijeratne; Ashley L Babyak; Hanna R Marks; Alan D Brooks; Poonam Tewary; Li-Jiang Xuan; Wen-Qiong Wang; Thomas J Sayers; A A Leslie Gunatilaka
Journal:  J Nat Prod       Date:  2017-06-15       Impact factor: 4.050

2.  Comparative Characterization of the Leaf Tissue of Physalis alkekengi and Physalis peruviana Using RNA-seq and Metabolite Profiling.

Authors:  Atsushi Fukushima; Michimi Nakamura; Hideyuki Suzuki; Mami Yamazaki; Eva Knoch; Tetsuya Mori; Naoyuki Umemoto; Masaki Morita; Go Hirai; Mikiko Sodeoka; Kazuki Saito
Journal:  Front Plant Sci       Date:  2016-12-20       Impact factor: 5.753

3.  Synthesis of the Right-Side Structure of Type B Physalins.

Authors:  Masaki Morita; Shuntaro Kojima; Megumi Ohkubo; Hiroyuki Koshino; Daisuke Hashizume; Go Hirai; Keiji Maruoka; Mikiko Sodeoka
Journal:  Isr J Chem       Date:  2016-11-09       Impact factor: 3.333

Review 4.  Natural Products from Physalis alkekengi L. var. franchetii (Mast.) Makino: A Review on Their Structural Analysis, Quality Control, Pharmacology, and Pharmacokinetics.

Authors:  Jing Yang; Yanping Sun; Feng Cao; Bingyou Yang; Haixue Kuang
Journal:  Molecules       Date:  2022-01-21       Impact factor: 4.411

5.  Production and Structural Diversification of Withanolides by Aeroponic Cultivation of Plants of Solanaceae: Cytotoxic and Other Withanolides from Aeroponically Grown Physalis coztomatl.

Authors:  Ya-Ming Xu; E M Kithsiri Wijeratne; Manping X Liu; Lijiang Xuan; Wenqiong Wang; A A Leslie Gunatilaka
Journal:  Molecules       Date:  2022-01-28       Impact factor: 4.411

6.  Isolation and characterisation of irinans, androstane-type withanolides from Physalis peruviana L.

Authors:  Annika Stein; Dave Compera; Bianka Karge; Mark Brönstrup; Jakob Franke
Journal:  Beilstein J Org Chem       Date:  2019-08-23       Impact factor: 2.883

Review 7.  Natural Withanolides in the Treatment of Chronic Diseases.

Authors:  Peter T White; Chitra Subramanian; Hashim F Motiwala; Mark S Cohen
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.